EU Court Confirms European Commission’s Decision on Pay-for-Delay Agreements

By and on October 20, 2016

On 8 September 2016, the General Court of the European Union upheld the European Commission’s decision in which the antitrust regulator imposed fines of approximately EUR 150 million on Lundbeck and a number of generic companies for entering into reverse settlement agreements which delayed the entry of cheaper generic versions of a blockbuster antidepressant.

The Commission had first hinted that patent settlement agreements causing delayed generic entry might be problematic in its 2009 report on the Pharmaceutical Sector Inquiry.

Mélanie BruneauMélanie Bruneau
Mélanie Bruneau advises clients from a variety of industrial sectors, including transport, manufacturing, chemicals and IT, on the legal aspects of their business activities, with particular emphasis on regulatory compliance. Read Mélanie Bruneau's full bio.


AvatarMcDermott Will & Emery



STAY CONNECTED

TOPICS

ARCHIVES